Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060496 · ClinicalTrials.gov registry record · NA
Theta Burst Stimulation for Alcohol Use Disorder
A NA study, sponsored by Gopalkumar Rakesh.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT06060496: Completed NA study, sponsored by Gopalkumar Rakesh.
NCT06060496 is a NA study that has completed, run by Gopalkumar Rakesh. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06060496, a NA study, has completed, sponsored by Gopalkumar Rakesh.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The study will examine the effects of two continuous theta burst stimulation (cTBS) sessions (given in a single day) on resting state functional MRI (fMRI), alcohol cue related attentional bias and alcohol craving in patients with alcohol use disorder (AUD).
Primary Outcome
Craving measured using the Penn alcohol craving scale (PACS) that has five items and is rated on a scale of 1 to 6. Minimum score is 1 and maximum score is 30. Higher score equates to increased craving
Interventions
- DEVICE Active cTBS
- DEVICE Sham cTBS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
What the finished NCT06060496 record still lists
NCT06060496 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Active cTBS is the first listed.
NCT06060496 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06060496 about?
NCT06060496 is a clinical study titled "Theta Burst Stimulation for Alcohol Use Disorder". The study will examine the effects of two continuous theta burst stimulation (cTBS) sessions (given in a single day) on resting state functional MRI (fMRI), alcohol cue related attentional bias and alcohol craving in patients with alcohol use disorder (AUD).
What is the current status of trial NCT06060496?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-10-01. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT06060496?
The interventions under investigation include: Active cTBS (DEVICE), Sham cTBS (DEVICE).
Who is sponsoring clinical trial NCT06060496?
This trial is sponsored by Gopalkumar Rakesh, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06060496's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI